April 2019

Looking Back on 2020: The Year of Pirouettes and Pivots

Last year. 2020. The year that so much changed. 2020 was an unprecedented year that caused many of us to pause suddenly. We paused to think, shift, regroup, realign, and to quite frankly, survive...As 2020 showed us, we are preparing for the best and yes, we can pivot if needed. 

Volunteer Spotlight: Rebekah Hall

Author: Rebekah Hall Meet Rebekah Hall. Rebekah is a doctor of clinical psychology, mother of 3, CMV advocate, and much more! We're excited to feature Rebekah in our volunteer spotlight during volunteer month. 

Top 5 Takeaways from CMV 2019

Before we dive into the key discussion points – one underlying theme was ever-present from our perspective – it was and continues to be deeply moving to see how many global professionals are devoting their lives to advancing congenital CMV research. Please know that we see you. And we appreciate you.

National CMV Foundation Nominates Congenital CMV for RUSP Newborn Screening

‚ÄčNational CMV Foundation and the CMV RUSP Nomination Team are excited to announce we have completed the submission of cytomegalovirus to the Recommended Uniform Screening Panel (RUSP). Administered by the Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children (SACHDNC), part of the Department of Health and Human Services, the RUSP is a list of 35 core conditions and 26 secondary conditions that all newborns in the US are recommended to be screened for.

CMV Awareness: What Are We Really Measuring?

Author: Kathleen M. Muldoon & Seth D. Dobson Because there is currently no CMV vaccine, it is important that women are informed of behaviors that can help to prevent CMV infection during pregnancy. CMV infection in mothers is preventable. Yet, most women have never heard of the virus. Estimates of the percentage of women that have heard of CMV range from 9-20%, globally.